Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT06165744




Registration number
NCT06165744
Ethics application status
Date submitted
4/12/2023
Date registered
11/12/2023
Date last updated
27/08/2024

Titles & IDs
Public title
Next Generation Cataract and Vitreoretinal Surgery Study
Scientific title
Next Generation Cataract and Vitreoretinal Surgery Study
Secondary ID [1] 0 0
CTV678-E001
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Ophthalmic Surgery 0 0
Condition category
Condition code
Eye 0 0 0 0
Diseases / disorders of the eye

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - UNITY VCS
Treatment: Surgery - Eye surgery

Experimental: UNITY VCS - Eye surgery performed with UNITY VCS


Treatment: Devices: UNITY VCS
Investigational device used during anterior and posterior segment ophthalmic surgery.

Treatment: Surgery: Eye surgery
Eye surgery performed with UNITY VCS
Intervention code [1] 0 0
Treatment: Devices
Intervention code [2] 0 0
Treatment: Surgery
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Percent of 'yes' responses to the binary question, "Did UNITY VCS using vitreoretinal or combined surgical functionality perform per the intended use as defined in protocol Section 5.1?"
Timepoint [1] 0 0
Day 0 operative
Secondary outcome [1] 0 0
Total time in the eye
Timepoint [1] 0 0
Day 0 operative
Secondary outcome [2] 0 0
Percent of 'yes' responses to the binary question, "Was anatomical success achieved for intended treatment (e.g., macular hole closure, retinal attachment, etc. as applicable for the patient's condition)?"
Timepoint [2] 0 0
Month 3 Postoperative
Secondary outcome [3] 0 0
Change from preoperative in Best Corrected Distance Visual Acuity (BCDVA) at Month 3 postoperative
Timepoint [3] 0 0
Preoperative (Day -30 to 0), Month 3 Postoperative

Eligibility
Key inclusion criteria
Key

* Requires posterior segment surgery in the operating room with or without simultaneous cataract surgery;
* Clear media except for cataract and vitreous hemorrhage;
* In simultaneous cataract and vitreoretinal surgery, eligible to undergo primary hydrophobic acrylic intraocular lens (IOL) implantation into the capsular bag;
* Other protocol-defined inclusion criteria may apply.

Key
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Previous vitrectomy in the operative eye aside from those requiring silicone oil removal;
* Neovascular or uncontrolled glaucoma;
* Planned glaucoma or postoperative surgeries during study aside from silicone oil removal;
* Inadequate pupil dilation (less than 6 millimeters);
* Other protocol-defined exclusion criteria may apply.

Study design
Purpose of the study
Treatment
Allocation to intervention
Not applicable
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
27/02/2024
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
19/08/2024
Sample size
Target
Accrual to date
Final
119
Recruitment in Australia
Recruitment state(s)
NSW,SA,VIC
Recruitment hospital [1] 0 0
Retina and Macula Specialists - Hurstville
Recruitment hospital [2] 0 0
Retina Associates - Southwest Retina - Liverpool
Recruitment hospital [3] 0 0
Sydney Retina Clinic & Day Surgery - Sydney
Recruitment hospital [4] 0 0
Adelaide Eye & Retina Centre - Adelaide
Recruitment hospital [5] 0 0
Pennington Eye Clinic - North Adelaide
Recruitment hospital [6] 0 0
St John of God Eye Centre - Geelong
Recruitment postcode(s) [1] 0 0
2220 - Hurstville
Recruitment postcode(s) [2] 0 0
2170 - Liverpool
Recruitment postcode(s) [3] 0 0
2000 - Sydney
Recruitment postcode(s) [4] 0 0
5000 - Adelaide
Recruitment postcode(s) [5] 0 0
5006 - North Adelaide
Recruitment postcode(s) [6] 0 0
3220 - Geelong

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Alcon Research
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of this study is to obtain device-specific safety and performance clinical data to support marketability and to collect formal user feedback.
Trial website
https://clinicaltrials.gov/study/NCT06165744
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Sr. Clinical Operations Lead, Surgical
Address 0 0
Alcon Research, LLC
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT06165744